Security key
10919W405
BRIGHT MINDS BIOSCIENCES INC. - Common Shares, no par value (DRUG)
CUSIP: 10919W405
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Shares, no par value
- Shares outstanding
- 9,846,380
- Total 13F shares
- 6,040,789
- Share change
- +796,798
- Total reported value
- $366,118,700
- Price per share
- $60.66
- Number of holders
- 63
- Value change
- +$48,861,748
- Number of buys
- 37
- Number of sells
- 14
Report period
Q3 2025
Institutions
63
Top holders
10
DRUG full security history
Newer quarter: Q4 2025
Previous quarter: Q2 2025
BRIGHT MINDS BIOSCIENCES INC. SEC filings
BRIGHT MINDS BIOSCIENCES INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 10919W405
Recent filing periods:
Top shareholders of DRUG - BRIGHT MINDS BIOSCIENCES INC. - Common Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Adage Capital Management, L.P. |
13D/G
|
— |
5.6%
|
395,743
|
$24,005,770 | $0 | 30 Sep 2025 | |
| Point72 Asset Management, L.P. |
13D/G
13F
|
Company |
3%
|
135,189
|
$4,175,988 | $0 | 31 Dec 2024 | |
| RA CAPITAL MANAGEMENT, L.P. |
13D/G
|
— |
2.9%
|
206,427
|
$6,376,530 | $0 | 31 Mar 2025 | |
| Sio Capital Management, LLC |
13F
13D/G
|
Company |
2.7%
from 13D/G
|
512,338
|
$13,377,145 | — | 30 Jun 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
12%
|
1,145,660
|
$30,216,783 | — | 30 Jun 2025 | |
| Cormorant Asset Management, LP |
13F
|
Company |
11%
|
1,059,331
|
$27,659,132 | — | 30 Jun 2025 | |
| Commodore Capital LP |
13F
|
Company |
5.1%
|
500,000
|
$13,055,000 | — | 30 Jun 2025 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
4.3%
|
420,690
|
$10,984,216 | — | 30 Jun 2025 | |
| Vivo Capital, LLC |
13F
|
Company |
2.6%
|
251,572
|
$6,568,545 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
|
Company |
2.1%
|
209,677
|
$5,474,666 | — | 30 Jun 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
2%
|
200,000
|
$5,222,000 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.6%
|
162,069
|
$4,231,621 | — | 30 Jun 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.1%
|
111,371
|
$2,907,897 | — | 30 Jun 2025 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.7%
|
69,004
|
$1,801,692 | — | 30 Jun 2025 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.66%
|
65,431
|
$1,708,403 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.58%
|
57,521
|
$1,501,872 | — | 30 Jun 2025 | |
| Walleye Capital LLC |
13F
|
Company |
0.54%
|
53,430
|
$1,395,057 | — | 30 Jun 2025 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.49%
|
48,474
|
$1,265,656 | — | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.32%
|
31,983
|
$835,076 | — | 30 Jun 2025 | |
| PLATINUM INVESTMENT MANAGEMENT LTD |
13F
|
Company |
0.29%
|
28,308
|
$739,122 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.26%
|
25,626
|
$669,094 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.25%
|
24,655
|
$643,742 | — | 30 Jun 2025 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.19%
|
19,164
|
$500,372 | — | 30 Jun 2025 | |
| AdvisorShares Investments LLC |
13F
|
Company |
0.15%
|
14,481
|
$378,099 | — | 30 Jun 2025 | |
| READYSTATE ASSET MANAGEMENT LP |
13F
|
Company |
0.14%
|
13,975
|
$364,887 | — | 30 Jun 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.13%
|
12,487
|
$326,036 | — | 30 Jun 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.12%
|
11,604
|
$302,980 | — | 30 Jun 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.09%
|
8,702
|
$227,211 | — | 30 Jun 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.09%
|
8,393
|
$219,141 | — | 30 Jun 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.07%
|
6,612
|
$172,633 | — | 30 Jun 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.06%
|
5,486
|
$143,240 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.05%
|
4,734
|
$123,605 | — | 30 Jun 2025 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.04%
|
4,100
|
$107,051 | — | 30 Jun 2025 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.03%
|
2,513
|
$65,614 | — | 30 Jun 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.02%
|
2,378
|
$62,090 | — | 30 Jun 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.02%
|
2,173
|
$17,341 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.02%
|
1,914
|
$49,974 | — | 30 Jun 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.02%
|
1,632
|
$43,141 | — | 30 Jun 2025 | |
| Police & Firemen's Retirement System of New Jersey |
13F
|
Company |
0.01%
|
1,079
|
$28,173 | — | 30 Jun 2025 | |
| STRS OHIO |
13F
|
Company |
0.01%
|
900
|
$23,499 | — | 30 Jun 2025 | |
| Legal & General Group Plc |
13F
|
Company |
0.01%
|
513
|
$13,530 | — | 30 Jun 2025 | |
| Ameritas Investment Partners, Inc. |
13F
|
Company |
0%
|
470
|
$12,272 | — | 30 Jun 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
457
|
$11,932 | — | 30 Jun 2025 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0%
|
287
|
$7,494 | — | 30 Jun 2025 | |
| AMALGAMATED BANK |
13F
|
Company |
0%
|
157
|
$4,000 | — | 30 Jun 2025 | |
| FMR LLC |
13F
|
Company |
0%
|
79
|
$2,063 | — | 30 Jun 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
65
|
$2,000 | — | 30 Jun 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
55
|
$1,436 | — | 30 Jun 2025 | |
| Sterling Capital Management LLC |
13F
|
Company |
0%
|
11
|
$287 | — | 30 Jun 2025 |
Institutional Holders of BRIGHT MINDS BIOSCIENCES INC. - Common Shares, no par value (DRUG) as of Q3 2025
As of 30 Sep 2025,
BRIGHT MINDS BIOSCIENCES INC. - Common Shares, no par value (DRUG) was held by
63 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,040,789 shares.
The largest 10 holders included
JANUS HENDERSON GROUP PLC, Cormorant Asset Management, LP, Vivo Capital, LLC, Commodore Capital LP, PERCEPTIVE ADVISORS LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., BRAIDWELL LP, BlackRock, Inc., MORGAN STANLEY, and Sio Capital Management, LLC.
This page lists
63
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
46
Q3 2025 holders
63
Holder diff
17
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.